文献速递妇科

EGFL6促进子宫内膜癌细胞迁移和增殖

EGFL6 promotes endometrial cancer cell migration and proliferation.
PubMed 文献 · Gynecol Oncol · 2024-02-17

EGFL6是由脂肪细胞产生的生长因子,在多种肿瘤中上调并参与肿瘤发生。本研究评估EGFL6对子宫内膜癌的影响,发现EGFL6在子宫内膜癌中上调,高表达预测患者预后不良,通过激活MAPK通路促进细胞增殖和迁移,在异种移植模型中过表达增加肿瘤生长而敲低减少肿瘤生长。

要点

  • EGFL6在子宫内膜癌中上调,主要见于拷贝数高肿瘤。
  • 肿瘤EGFL6高表达预测患者预后不良。
  • EGFL6激活MAPK通路,增加细胞增殖和迁移。

核心结论

  • EGFL6是预后不良子宫内膜癌的标志物,驱动癌细胞增殖和生长。
  • EGFL6是子宫内膜癌的潜在治疗靶点。

研究设计与样本

  • 研究评估EGFL6在子宫内膜癌中的表达及其与患者结局的相关性,使用人类蛋白质图谱和TCGA数据。
  • 体外使用EGFL6处理、表达上调和shRNA敲低评估对3种子宫内膜癌细胞系增殖和迁移的影响。
  • 评估EGFL6表达和敲低对肿瘤生长的影响,并使用蛋白质印迹评估EGFL6对MAPK磷酸化的影响。

主要发现

  • EGFL6在子宫内膜癌中上调,主要见于拷贝数高肿瘤。
  • 肿瘤EGFL6高表达预测患者预后不良。
  • EGFL6激活MAPK通路,增加细胞增殖和迁移。
  • 在异种移植模型中,EGFL6过表达增加子宫内膜癌肿瘤生长,而EGFL6敲低减少子宫内膜癌肿瘤生长。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: EGFL6, a growth factor produced by adipocytes, is upregulated in and implicated in the tumorigenesis of multiple tumor types. Given the strong link between obesity and endometrial cancer, we sought to determine the impact of EGFL6 on endometrial cancer. METHODS: EGFL6 expression in endometrial cancer and correlation with patient outcomes was evaluated in the human protein atlas and TCGA. EGFL6 treatment, expression upregulation, and shRNA knockdown were used to evaluate the impact of EGFL6 on the proliferation and migration of 3 endometrial cancer cell lines in vitro. Similarly, the impact of EGFL6 expression and knockdown on tumor growth was evaluated. Western blotting was used to evaluate the impact of EGFL6 on MAPK phosphorylation. RESULTS: EGFL6 is upregulated in endometrial cancer, primarily in cony-number high tumors. High tumor endometrial cancer expression of EGFL6 predicts poor patient prognosis. We find that EGFL6 acts to activate the MAPK pathway increasing cellular proliferation and migration. In xenograft models, EGFL6 overexpression increases endometrial cancer tumor growth while EGFL6 knockdown decreases endometrial cancer tumor growth. CONCLUSIONS: EGFL6 is a marker of poor prognosis endometrial cancers, driving cancer cell proliferation and growth. As such EGFL6 represents a potential therapeutic target in endometrial cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Garrett AA, Bai S, Cascio S, et al. EGFL6 promotes endometrial cancer cell migration and proliferation. Gynecol Oncol. 2024. PMID: 38368816. doi:10.1016/j.ygyno.2024.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。